NEW YORK (TheStreet) -- RATINGS CHANGES Ambarella was downgraded at Needham to underperform from hold. Valuation call, as the stock is up 65% year to date, Needham said. Gilead was upgraded at Morgan Stanley to overweight from equal-weight. Twelve-month price target is $104. Fear over Abbvie pricing has created a buying opportunity, Morgan Stanley said. Must Read: 6 No-Brainer Tax Moves You Absolutely Want to Make by Dec. 31 Halyard Health was initiated with an outperform rating at JMP Securities. Twelve-month price target is $50. Company should benefit from lower raw materials costs and can make a small acquisition to augment growth, JMP Securities said. Hovnanian was upgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: HOV Ratings Report. Liberty Property Trust was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: LPT Ratings Report. Must Read: 10 Stocks Billionaire David Einhorn Loves for 2015 Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here. Follow TheStreet on Twitter and become a fan on Facebook.
Click to view a price quote on HYH.
from Latest TSC Headlines http://feeds.thestreet.com/~r/tsc/feeds/rss/latest-stories/~3/dVIdPYNR8s0/analysts-actions-ambarella-gilead-halyard-health-and-more.html
No comments:
Post a Comment